It is a broadly described annual report of Orion Pharma Limited in the year of 2014. During the financial year, The Company’s Total Revenue stood at BDT 10,706.70 million which is ultimately 2.77% lower than previous years consolidated sales revenue. Gross Profit BDT 925.14 million. Net Operating Profit BDT 448.49 million. Net Profit before Tax BDT 427.13 million. The Company earns the consolidated net profit after tax of BDT 994.09 million for the financial year 2014 as against BDT 908.86 million in the previous year showing a growth of 938%. The consolidated basic earnings per share for the year 2014 is BDT 4.25 compared to previous year’s earnings per share of BDT 4.06.
The Board of Directors of Orion Pharma Limited has recommended @15% cash dividend to its shareholders for the year 2014. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.
More Annual Report of Orion Pharma Limited: